Taiju Nakamura

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Eisai Company, Limited. Active years: 2003-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taiju Nakamura. Retrieved from https://idiyas.com/inventor/taiju-nakamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 62.5

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 90(Granted Patents)

Location History:

Ibaraki, JP (2003 - 2006)
Kashima-gun, JP (2009)
Kamisu, JP (2009 - 2021)

Company Filing History:

6 out of 530

Eisai R&d Management Co., Ltd.

patents

2 out of 677

Eisai Company, Limited

patents

Years Active: 2003-2021

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11186547 - High-purity quinoline derivative and method for manufacturing same (2021-11-30),

2. 10822307 - High-purity quinoline derivative and method for manufacturing same (2020-11-03),

3. 10407393 - High-purity quinoline derivative and method for manufacturing same (2019-09-10),

4. 10259791 - High-purity quinoline derivative and method for manufacturing same (2019-04-16),

5. 7612208 - Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same (2009-11-03),

6. 7585982 - Methods for producing isoindole derivatives (2009-09-08),

7. 7084268 - Carbapenem compound crystals and interjection preparations (2006-08-01),

8. 6642377 - Process for the preparation of basic antibiotic-inorganic acid addition salts and intermediate oxalates (2003-11-04),

Title: The Innovations of Taiju Nakamura

Introduction

Taiju Nakamura is a prominent inventor based in Kamisu, Japan. He has made significant contributions to the field of chemistry, particularly in the development of high-purity quinoline derivatives. With a total of 8 patents to his name, Nakamura's work has had a notable impact on various applications in the pharmaceutical industry.

Latest Patents

Nakamura's latest patents include a high-purity quinoline derivative and a method for manufacturing the same. This invention provides a compound represented by formula (IV) or a salt thereof, wherein the content of the compound represented by formula (I) is 350 ppm by mass or less. This innovation is crucial for ensuring the quality and efficacy of pharmaceutical products.

Career Highlights

Throughout his career, Taiju Nakamura has worked with notable companies such as Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of medicinal chemistry.

Collaborations

Nakamura has collaborated with talented individuals in his field, including Yusuke Ayata and Taichi Abe. These partnerships have fostered a creative environment that has led to the development of innovative solutions in chemistry.

Conclusion

Taiju Nakamura's contributions to the field of chemistry, particularly through his patents and collaborations, highlight his role as a significant inventor. His work continues to influence the pharmaceutical industry and drive advancements in chemical research.

Profile summary based on public USPTO records.